A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma (PAAD) carries the lowest survival rate of all major organ cancers, which is of dismal prognosis and high mortality rate. Thus, the present study attempted to identify a few novel prognostic biomarkers and establish an immune-related prognostic signature which could predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao, Li, Xiaomian, Xie, Jun, Zhu, Qian, Yuan, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956421/
https://www.ncbi.nlm.nih.gov/pubmed/35342420
http://dx.doi.org/10.1155/2022/8909631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956421/
https://www.ncbi.nlm.nih.gov/pubmed/35342420
http://dx.doi.org/10.1155/2022/8909631

Ejemplares similares